JP Morgan Upgrades Phibro Animal Health to Overweight, Raises Price Target to $35
Benzinga Newsdesk 1 year ago
NewsUpgradesPrice TargetAnalyst Ratings
JP Morgan analyst Ekaterina Knyazkova upgrades Phibro Animal Health (NASDAQ:PAHC) from Neutral to Overweight and raises the price target from $25 to $35.
JP Morgan analyst Ekaterina Knyazkova upgrades Phibro Animal Health (NASDAQ:PAHC) from Neutral to Overweight and raises the price target from $25 to $35.